Controls | Crohn’s disease | Ulcerative colitis | |
---|---|---|---|
*Values are mean (SD) [range]. | |||
†Crohn’s disease activity index (CDAI).25 | |||
‡Activity assessed according to Rachmilewitz.26 | |||
¶Some patients had combined therapy. | |||
n | 75 | 111 | 69 |
Age (y)* | 36.8 (14.5) [18.2–78.8] | 33.4 (13.6) [19.1–75.8] | 36.4 (12.4) [18.8–64.7] |
Sex (M/F) | 33/42 | 50/61 | 36/33 |
Disease duration (y)* | 3.12 (4.93) [0–23.3] | 4.69 (6.8) [0–23.8] | |
Activity score (mean (SD))* | 257 (67)† | 7.7 (2.1)‡ | |
Medication¶ | |||
None | 75 | 25 | 10 |
Aminosalicylate | 46 | 36 | |
Systemic steroid | 30 | 21 | |
Topical steroid | 4 | 2 | |
Azathioprine | 12 | 2 | |
Antibiotic | 11 | – | |
Ciclosporine | 1 | 1 |